| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/09/2012 | US20120034243 Method of Administering an Antibody |
| 02/09/2012 | US20120034222 Nitric Oxide Generating Medical Devices |
| 02/09/2012 | US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases |
| 02/09/2012 | US20120034201 Composition for regulating lipid metabolism |
| 02/09/2012 | US20120034195 Placental stem cells derive from post-partum manmalian placenta, and uses and methods of treatment using said cells |
| 02/09/2012 | US20120034193 Treatment of neurotrophic factor mediated disorders |
| 02/09/2012 | US20120034191 Extracellular matrix compositions for tissue regeneration |
| 02/09/2012 | US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof |
| 02/09/2012 | US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
| 02/09/2012 | US20120034163 Non-invasive tools for detecting vulnerable atherosclerotic plaques |
| 02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
| 02/09/2012 | CA2807283A1 Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease |
| 02/09/2012 | CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 02/09/2012 | CA2806657A1 Highly crystalline valsartan |
| 02/09/2012 | CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 02/09/2012 | CA2804377A1 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| 02/08/2012 | EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| 02/08/2012 | EP2415759A1 CETP inhibitors |
| 02/08/2012 | EP2415755A1 Plasminogen activator inhibitor-1 inhibitor |
| 02/08/2012 | EP2415749A1 New salvianolic acid compound l, preparation method and use thereof |
| 02/08/2012 | EP2415748A1 Novel anti-inflammatory compounds |
| 02/08/2012 | EP2415474A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
| 02/08/2012 | EP2415467A1 Production method for ubiquinone powder for use in preparations and product thereof |
| 02/08/2012 | EP2414332A1 Acrylamide compounds and the use thereof |
| 02/08/2012 | EP2414331A1 5-ht receptor modulating compounds |
| 02/08/2012 | EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/08/2012 | EP2413954A1 Compositions and methods for treatment of aortic fibrosis |
| 02/08/2012 | EP2413942A1 Use of ribose in first response to acute myocardial infarction |
| 02/08/2012 | EP2413939A1 Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid |
| 02/08/2012 | EP2413931A1 Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
| 02/08/2012 | EP2413930A1 Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy |
| 02/08/2012 | EP2413928A1 Use of flavonoids to increase the bioavailability of hesperetin |
| 02/08/2012 | EP2195014B1 Use of g-csf for the treatment of stroke |
| 02/08/2012 | EP2098515B1 Substituted carbinol compound |
| 02/08/2012 | EP1902141B1 Adamts13-comprising compositions having thrombolytic activity |
| 02/08/2012 | CN1652757B Edg受体结合剂在癌症中的应用 Edg receptor binding agents in cancer of the |
| 02/08/2012 | CN102348678A Novel eicosanoid derivatives |
| 02/08/2012 | CN102344900A Engineering bacterium for expressing antihypertensive peptide and method for preparing antihypertensive peptide |
| 02/08/2012 | CN102344880A Health wine and production method thereof |
| 02/08/2012 | CN102344475A Scutellarin derivative and preparation method and application thereof |
| 02/08/2012 | CN102344468A Preparation and use of novel AKT/PKB kinase agonists |
| 02/08/2012 | CN102344442A Novel crystal form of tandospirone citrate and preparation method and application thereof |
| 02/08/2012 | CN102344416A Pyridazine derivative and application thereof serving as anti-small RNA (Ribose Nucleic Acid) virus infection medicament |
| 02/08/2012 | CN102344409A Amlodipine crystal, medicine composition of amlodipine crystal and benazepril as well as method for preparing medicine composition |
| 02/08/2012 | CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 02/08/2012 | CN102343100A Method for quickly preparing rutin inclusion compound |
| 02/08/2012 | CN102343094A Compositions and methods of delivery of pharmacological agents |
| 02/08/2012 | CN102343073A Medicament for treating vasculitis and cerebral infarction |
| 02/08/2012 | CN102343072A Formulation and method for treating gall bladder meridian and heart meridian diseases by virtue of Chinese medicinal herb treatment |
| 02/08/2012 | CN102343049A Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity |
| 02/08/2012 | CN102343042A Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus |
| 02/08/2012 | CN102343037A Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
| 02/08/2012 | CN102343024A Formula of traditional Chinese medicine for treating hemorrhoid |
| 02/08/2012 | CN102343023A Medicinal composition and preparation method and application thereof |
| 02/08/2012 | CN102343013A Camellia saponin controlled release tablet and preparation method thereof |
| 02/08/2012 | CN102343002A Chinese medicinal composition for treating arrhythmia |
| 02/08/2012 | CN102342997A Traditional Chinese medicine composition used for treating apoplexy |
| 02/08/2012 | CN102342967A Thin film coated tablets containing vitamin, ginseng and zinc sulfate and preparation method thereof |
| 02/08/2012 | CN102342964A Andrographolidume sustained-release preparation as well as preparation method and use of same |
| 02/08/2012 | CN102342948A New oral solid medicinal composition and preparation method thereof |
| 02/08/2012 | CN102342944A Medicament composition for treating hypertension |
| 02/08/2012 | CN102342943A Brand new oral solid medicinal composition and its preparation method |
| 02/08/2012 | CN102342942A Novel oral solid medicinal composition and preparation method thereof |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN102342937A Amlodipine and candesartan pharmaceutical composition and preparation method thereof |
| 02/08/2012 | CN102342936A Medicinal composition of amlodipine and atorvastatin calcium and its preparation method |
| 02/08/2012 | CN102342924A Medicine composition containing agomelatine |
| 02/08/2012 | CN102342921A Pharmaceutical composition of prasugrel hydrobromide acetate compound |
| 02/08/2012 | CN102342917A Slow release oral solid preparation with Nilvadipine as active component |
| 02/08/2012 | CN102342915A Method for preparing antihypertensive peptide microsphere with intestine site-specific delivery drugs release effect |
| 02/08/2012 | CN102342912A Candesartan cilexetil nanoemulsion and preparation method thereof |
| 02/08/2012 | CN102342909A Preparation method of salvianic acid A sodium injection |
| 02/08/2012 | CN102342907A Dronedarone solid dispersoid and preparation method thereof |
| 02/08/2012 | CN102342900A Application of hibiscus flower essential oil |
| 02/08/2012 | CN102133198B 一种酒石酸艾芬地尔冻干粉针剂及其制备方法 One kind of tartaric acid Ifenprodil freeze-dried powder and its preparation method |
| 02/08/2012 | CN101940552B 中药莽草酸粉针剂 TCM shikimic acid powder |
| 02/08/2012 | CN101874869B 一种中药组合物中马钱苷的含量测定方法 A method of determination of the composition of traditional Chinese medicine loganin |
| 02/08/2012 | CN101850066B 中药组合物颗粒剂及其制备方法 Chinese medicine composition and its preparation method granules |
| 02/08/2012 | CN101709321B 一种燕麦多肽及其制备方法与应用 One kind of oat peptides and preparation method and application |
| 02/08/2012 | CN101647839B 三七总皂苷-丹参酮复合干粉吸入剂及其制备方法 Panax notoginseng saponins - Tan Composite dry powder inhaler and its preparation method |
| 02/08/2012 | CN101590038B 一种口服缓释降压组合物 An oral sustained release compositions buck |
| 02/08/2012 | CN101357125B 益母草碱在制备防治缺血性心肌病药物中的用途 Leonurine in the preparation of drug prevention and treatment of ischemic cardiomyopathy in use |
| 02/08/2012 | CN101342238B 一种治疗心脑血管疾病的药物组合物 A method of treating cardiovascular and cerebrovascular diseases, the pharmaceutical composition |
| 02/08/2012 | CN101204402B 一种水蛭的真空冷冻干燥工艺 One kind of vacuum freeze-drying process leech |
| 02/07/2012 | US8110706 Formoterol tartrate process and polymorph |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110587 Aryl ureas as kinase inhibitors |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 02/07/2012 | US8110564 Bile acid or bile salt fatty acid conjugates |
| 02/07/2012 | US8110367 Methods for diagnosing renal disorders |
| 02/07/2012 | CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 02/07/2012 | CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
| 02/07/2012 | CA2471046C Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 02/07/2012 | CA2466536C Transdermal transport of compounds |
| 02/07/2012 | CA2452923C Peptide-based compounds for targeting integrin receptors |
| 02/07/2012 | CA2383850C Prevention and treatment of mycoplasma-associated diseases |
| 02/02/2012 | WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same |